PT1667693E - Composições e métodos para usar corpos lamelares com fins terapêuticos - Google Patents
Composições e métodos para usar corpos lamelares com fins terapêuticos Download PDFInfo
- Publication number
- PT1667693E PT1667693E PT4768271T PT04768271T PT1667693E PT 1667693 E PT1667693 E PT 1667693E PT 4768271 T PT4768271 T PT 4768271T PT 04768271 T PT04768271 T PT 04768271T PT 1667693 E PT1667693 E PT 1667693E
- Authority
- PT
- Portugal
- Prior art keywords
- compositions
- methods
- therapeutic purposes
- lamellar bodies
- lamellar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0322448.2A GB0322448D0 (en) | 2003-09-25 | 2003-09-25 | Using lamellar bodies to modify linear biological macro molecules |
US10/827,172 US20050070877A1 (en) | 2003-09-25 | 2004-04-19 | Compositions and methods of using lamellar bodies for modifying linear biological macromolecules |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1667693E true PT1667693E (pt) | 2015-11-12 |
Family
ID=29286803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT4768271T PT1667693E (pt) | 2003-09-25 | 2004-08-31 | Composições e métodos para usar corpos lamelares com fins terapêuticos |
Country Status (9)
Country | Link |
---|---|
US (4) | US20050070877A1 (pt) |
CY (1) | CY1116815T1 (pt) |
DK (1) | DK1667693T3 (pt) |
ES (1) | ES2543979T3 (pt) |
GB (1) | GB0322448D0 (pt) |
HU (1) | HUE025129T2 (pt) |
NZ (1) | NZ546388A (pt) |
PT (1) | PT1667693E (pt) |
SI (1) | SI1667693T1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0007150D0 (en) * | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
GB0322448D0 (en) * | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
US10471212B2 (en) * | 2009-10-29 | 2019-11-12 | W. L. Gore & Associates, Inc. | Silicone free drug delivery devices |
US9597458B2 (en) | 2009-10-29 | 2017-03-21 | W. L. Gore & Associates, Inc. | Fluoropolymer barrier materials for containers |
US11612697B2 (en) | 2010-10-29 | 2023-03-28 | W. L. Gore & Associates, Inc. | Non-fluoropolymer tie layer and fluoropolymer barrier layer |
AU2015204395B2 (en) * | 2011-05-27 | 2017-02-23 | W. L. Gore & Associates, Inc. | Fluoropolymer barrier materials for containers |
JP5701371B2 (ja) | 2012-12-28 | 2015-04-15 | 花王株式会社 | スフィンゴミエリン含有サプリメント |
US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
GB201511058D0 (en) * | 2015-06-23 | 2015-08-05 | Lamellar Biomedical Ltd | Compositions and methods for using lamellar bodies for therapeutic purposes |
JP2018533622A (ja) | 2015-09-28 | 2018-11-15 | アズーラ オフサルミックス エルティーディー. | マイボーム腺の脂質分泌を増加させるためのチオールおよびジスルフィド含有薬剤 |
EP3442519A4 (en) | 2016-04-14 | 2019-12-04 | Azura Opthalmics Ltd. | SELENIUM DISULFIDE COMPOSITIONS FOR USE IN THE TREATMENT OF MEIBOMIUS GLAND DYSFUNCTION |
CN115279458A (zh) | 2020-01-10 | 2022-11-01 | 阿祖拉眼科有限公司 | 组合物和敏感性说明 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925375A (en) | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
US5403592A (en) | 1987-08-25 | 1995-04-04 | Macnaught Pty Limited | Lubricant composition for rheumatism |
US5006343A (en) | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
FR2645878B1 (fr) | 1989-04-17 | 1994-02-25 | Institut Nal Sante Recherc Medic | Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes |
JPH02295933A (ja) | 1989-05-10 | 1990-12-06 | Wakamoto Pharmaceut Co Ltd | 封入純度の高いプラスミノーゲン活性化因子封入リポソームの製造法 |
WO1991012026A1 (en) | 1990-02-14 | 1991-08-22 | Macnaught Pty Limited | Means of reducing surgical adhesions |
FR2658418B1 (fr) * | 1990-02-20 | 1994-09-02 | Synthelabo | Compositions pharmaceutiques a base de phospholipides. |
ATE164230T1 (de) | 1991-05-29 | 1998-04-15 | Baxter Int | 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen |
WO1995008986A1 (en) | 1993-09-27 | 1995-04-06 | Smithkline Beecham Corporation | Camptothecin formulations |
US5462752A (en) | 1994-07-28 | 1995-10-31 | Prp, Inc. | Inhibition of platelet binding |
AUPM836794A0 (en) | 1994-09-23 | 1994-10-20 | University Of New England, The | Improved method and composition for the treatment of ulcers |
US5643599A (en) | 1995-06-07 | 1997-07-01 | President And Fellows Of Harvard College | Intracellular delivery of macromolecules |
CA2227065A1 (en) | 1995-07-21 | 1997-02-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
US5736157A (en) | 1995-10-11 | 1998-04-07 | Williams; Kevin Jon | Method of regulating cholesterol related genes, enzymes and other compounds, and pharmaceutical compositions |
AUPN766496A0 (en) | 1996-01-22 | 1996-02-15 | University Of New England, The | Method and composition for the potentiation of anti-inflammatory drugs |
DK1634949T3 (da) | 1997-05-08 | 2011-03-28 | Oncothyreon Inc | Fremgangsmåde til at generere aktiverede T-celler og antigen-inkuberede antigen-præsenterende celler |
WO1998053800A1 (en) | 1997-05-29 | 1998-12-03 | Applied Biotechnologies, Inc. | Compositions and methods for preventing adhesion |
SE9702698D0 (sv) | 1997-07-14 | 1997-07-14 | Stig Bengmark | Compositions for lubricating and separating tissues and biological membranes |
ES2191355T3 (es) | 1997-12-24 | 2003-09-01 | Britannia Pharmaceuticals Ltd | Uso de un tensioactivo para la preparacion de un medicamento para el tratamiento de trastornos del oido medio. |
GB9807298D0 (en) | 1998-04-03 | 1998-06-03 | Britannia Pharmaceuticals Ltd | Medicament |
EP0976403A1 (en) | 1998-07-30 | 2000-02-02 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Adjuvant comprising pulmonary surfactant |
US6290987B1 (en) | 1998-09-27 | 2001-09-18 | Generex Pharmaceuticals, Inc. | Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids |
US6193997B1 (en) | 1998-09-27 | 2001-02-27 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using membrane mimetics |
WO2000069412A1 (en) | 1999-05-14 | 2000-11-23 | Esperion Luv Development, Inc. | Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto |
GB0007150D0 (en) | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
CA2319928A1 (en) | 2000-09-18 | 2002-03-18 | Vasogen Ireland Limited | Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
GB0207653D0 (en) | 2002-04-03 | 2002-05-15 | Lamellar Therapeutics Ltd | Methods of using lamellar bodies for therapeutic purposes |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
CN1747738B (zh) | 2002-10-29 | 2010-11-24 | 川塞夫有限公司 | 缓释抗感染剂 |
GB0322448D0 (en) | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
-
2003
- 2003-09-25 GB GBGB0322448.2A patent/GB0322448D0/en not_active Ceased
-
2004
- 2004-04-19 US US10/827,172 patent/US20050070877A1/en not_active Abandoned
- 2004-08-31 PT PT4768271T patent/PT1667693E/pt unknown
- 2004-08-31 NZ NZ546388A patent/NZ546388A/en unknown
- 2004-08-31 SI SI200432263T patent/SI1667693T1/sl unknown
- 2004-08-31 HU HUE04768271A patent/HUE025129T2/en unknown
- 2004-08-31 DK DK04768271.1T patent/DK1667693T3/da active
- 2004-08-31 ES ES04768271.1T patent/ES2543979T3/es active Active
-
2008
- 2008-11-24 US US12/313,724 patent/US9173901B2/en not_active Expired - Fee Related
-
2013
- 2013-06-12 US US13/915,779 patent/US9750766B2/en active Active
-
2015
- 2015-09-23 CY CY20151100836T patent/CY1116815T1/el unknown
-
2017
- 2017-09-01 US US15/694,012 patent/US20180153936A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180153936A1 (en) | 2018-06-07 |
DK1667693T3 (da) | 2015-08-31 |
ES2543979T3 (es) | 2015-08-26 |
US20090111773A1 (en) | 2009-04-30 |
CY1116815T1 (el) | 2017-03-15 |
HUE025129T2 (en) | 2016-01-28 |
US20130280340A1 (en) | 2013-10-24 |
NZ546388A (en) | 2009-07-31 |
US9173901B2 (en) | 2015-11-03 |
SI1667693T1 (sl) | 2015-10-30 |
US9750766B2 (en) | 2017-09-05 |
US20050070877A1 (en) | 2005-03-31 |
GB0322448D0 (en) | 2003-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003259735A8 (en) | Small-mer compositions and methods of use | |
EP1696910A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF FIBROSIS | |
IL174627A0 (en) | Compositions and methods for treatment of burns | |
IL172194A0 (en) | Methods and compositions for treating amyloid-related diseases | |
EP1663259A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
IL172647A0 (en) | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | |
PL378368A1 (pl) | Kompozycje i sposoby wykorzystywane w skojarzonej terapii przeciwwirusowej | |
IL219406A0 (en) | Antiloading compositions and methods of selecting same | |
IL175427A0 (en) | Methods and compositions using thalidomide for the treatment and management of cancers and other diseases | |
EP1613266A4 (en) | METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF | |
EP1699431A4 (en) | COMPOSITIONS FOR THE TREATMENT OF EARLIER DISEASES AND APPLICATION PROCEDURES | |
AU2003286741A8 (en) | Methods and compositions for diagnosis and therapy of parkin-associated disorders | |
AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
ZA200600025B (en) | Methods and compositions for interferon therapy | |
EP1663255A4 (en) | WITHANAMID AND WITHANOLID COMPOSITIONS AND APPLICATION METHOD THEREFOR | |
GB0303609D0 (en) | Novel therapeutic method and compositions | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
SI1667693T1 (sl) | Sestave in postopki za uporabo lamelastih teles v terapevtske namene | |
EP1625141A4 (en) | GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF | |
GB0324523D0 (en) | Compositions and methods of treatment | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
GB0327050D0 (en) | Therapeutic methods compositions and uses | |
PL1667693T3 (pl) | Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych | |
GB0303600D0 (en) | Novel therapeutic method and compositions | |
EP1545539A4 (en) | COMPOSITIONS FOR INDUCING INCREASED G (B) -CHIMIOKIN LEVELS AND METHODS OF USE THEREOF |